Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| §112 only | 2 (33%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIKNIS, ZACHARY J | 2 | 68.5% | +32.6% |
| BERHANE, SELAM | 1 | 61.3% | +55.5% |
| FISCHER, JOSEPH | 1 | 43.2% | +45.2% |
| HOWARD, ZACHARY C | 1 | 63.9% | +38.2% |
| DEBERRY, REGINA M | 1 | 49.8% | +30.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17289420 | TREATMENT OF ANEMIA DUE TO VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES IN SUBJECTS WITH RING SIDEROBLASTS USING ACTIVIN-ACTRll LIGAND TRAPS | DEBERRY, REGINA M | 24d overdue |
| 18011261 | ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | MIKNIS, ZACHARY J | 21d |
| 18035329 | FORMULATIONS COMPRISING ACTRII POLYPEPTIDE VARIANTS | FISCHER, JOSEPH | 26d |
| 18010888 | ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE | HOWARD, ZACHARY C | 26d |
| 18328410 | TREATMENTS FOR HERMANSKY-PUDLAK SYNDROME | BERHANE, SELAM | 70d |
| 18954145 | ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | MIKNIS, ZACHARY J | 77d |
| Art Unit | Apps |
|---|---|
| 1658 | 3 |
| 1675 | 1 |
| 1674 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18954145 | ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | MIKNIS, ZACHARY J | 1658 | §103 | Non-Final OA | 77d | Pending | Nov 20, 2024 |
| 18328410 | TREATMENTS FOR HERMANSKY-PUDLAK SYNDROME | BERHANE, SELAM | 1675 | §103 | Non-Final OA | 70d | Pending | Jun 02, 2023 |
| 18035329 | FORMULATIONS COMPRISING ACTRII POLYPEPTIDE VARIANTS | FISCHER, JOSEPH | 1658 | Other | Non-Final OA | 26d | Pending | May 04, 2023 |
| 18011261 | ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | MIKNIS, ZACHARY J | 1658 | §112 | Final Rejection | 21d | Pending | Dec 19, 2022 |
| 18010888 | ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE | HOWARD, ZACHARY C | 1674 | §103 | Non-Final OA | 26d | Pending | Dec 16, 2022 |
| 17289420 | TREATMENT OF ANEMIA DUE TO VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES IN SUBJECTS WITH RING SIDEROBLASTS USING ACTIVIN-ACTRll LIGAND TRAPS | DEBERRY, REGINA M | 1647 | §112 | Final Rejection | 24d overdue | Pending | Apr 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial